Political prioritisation as a driver of vaccine introduction: Evidence from Nigeria’s HPV rollout

Cost of standard-of-care cancer treatment and financing gaps under AB PM-JAY in India

Choice of wording may influence global acceptance of adapted childhood cancer treatment guidelines

Multilevel factors shaping blinatumomab delivery across diverse LMICs

Building the cancer system of the future in UAE

Equitable HPV vaccination for all

Designing around lives: A decentralised, people-centred oncology care architecture from India

Zidesamtinib shows promising efficacy in TKI-naïve ROS1-positive advanced NSCLC

Isa-VRd shows sustained benefit in transplant-ineligible newly diagnosed multiple myeloma

Using artificial intelligence to improve lung cancer screening and risk prediction

Subcutaneous tarlatamab shows encouraging efficacy in previously treated extensive-stage SCLC

Pembrolizumab plus chemotherapy shows pathological responses in resectable pleural mesothelioma